Safety and Tolerability of 4975 in Patients Undergoing Arthroscopic Surgery to Repair the Rotator Cuff of the Shoulder

PHASE2TerminatedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

December 31, 2008

Conditions
Rotator Cuff Repair of the Shoulder
Interventions
DRUG

4975 - Highly purified capsaicin

Solution, 0.5 mg, single dose, injection

DRUG

4975 - Highly purified capsaicin

Solution, 0.75 mg, single dose, injection

DRUG

4975 - Highly purified capsaicin

Solution, 0.1 mg, Single dose, injection

DRUG

Placebo

Solution, single dose, injection

Trial Locations (4)

700-721

Kyungpook National university Hospital, Daegu

463-707

Seoul National University Hospital, Seoul

660-720

Gyeongsang National University Hospital, Jinju

137-040

Kangnam St. Mary's Hospital, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Anesiva, Inc.

INDUSTRY

NCT00672568 - Safety and Tolerability of 4975 in Patients Undergoing Arthroscopic Surgery to Repair the Rotator Cuff of the Shoulder | Biotech Hunter | Biotech Hunter